<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Herb/Saw_Palmetto.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:33:18 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="2161003">
<meta name="Category" content="Herb">
<meta name="Article" content="Saw_Palmetto">
<title>Palmito-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Palmito</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Saw_Palmetto.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Di Silverio F, Monti S, Sciarra A, et al. Effects of long-term treatment with
Serenoa repens (Permixon&#174;) on the concentrations and regional distribution of androgens
and epidermal growth factor in benign prostatic hyperplasia. <em>Prostate</em>
1998;37:77&#8211;83.</li>

<li class="Ref">Strauch G, Perles P, Vergult G, et al. Comparison of finasteride
(Proscar&#174;) and <em>Serenoa repens</em> (Permixon&#174;) in the inhibition of 5-alpha
reductase in healthy male volunteers. <em>Eur Urol</em> 1994;26:247&#8211;52.</li>

<li class="Ref">Wilt TJ, Ishani A, Stark G, et al. Saw palmetto extracts for treatment of
benign prostatic hyperplasia. <em>JAMA</em> 1998;280:160&#8211;9.</li>

<li class="Ref">Bach D, Ebeling L. Long-term drug treatment of benign prostatic
hyperplasia&#8212;results of a prospective 3-year multicenter study using Sabal extract IDS
89. <em>Phytomedicine</em> 1996;3:105&#8211;11.</li>

<li class="Ref">Carraro JC, Raynaud JP, Koch G, et al. Comparison of phytotherapy
(Permixon&#174;) with finasteride in the treatment of benign prostate hyperplasia: A
randomized international study of 1,098 patients. <em>Prostate</em> 1996;29:231&#8211;40.</li>

<li class="Ref">Metzker H, Kieser M, H&#246;lscher U. Efficacy of a combined Sabal-Urtica
preparation in the treatment of benign prostatic hyperplasia (BPH).<em>Urologe [B]</em>
1996;36:292&#8211;300.</li>

<li class="Ref">S&#246;keland J, Albrecht J. A combination of Sabal and Urtica extracts versus
finasteride in BPH (stage I and II according to Alken): a comparison of therapeutic efficacy
in a one-year double-blind study. <em>Urologe [A]</em> 1997;36:327&#8211;33.</li>

<li class="Ref">Brown DJ. <em>Herbal Prescriptions for Better Health.</em> Rocklin, CA: Prima
Publications, 1996, 167&#8211;72.</li>

<li class="Ref">Blumenthal M, Busse WR, Goldberg A, et al. (eds). <em>The Complete Commission
E Monographs: Therapeutic Guide to Herbal Medicines.</em> Boston, MA: Integrative Medicine
Communications, 1998, 201.</li>

<li class="Ref">Cheema P, El-Mefty O, Jazieh AR. Intraoperative haemorrhage associated with
the use of extract of Saw Palmetto herb: a case report and review of literature. <em>J Intern
Med</em> 2001;250:167&#8211;9.</li>

<li class="Ref">Carraro JC, Raynaud JP, Koch G, et al. Comparison of phytotherapy
(Permixon&#174;) with finasteride in the treatment of benign prostate hyperplasia: A
randomized international study of 1,098 patients. <em>Prostate</em> 1996;29:231&#8211;40.</li>

<li class="Ref">Bayne CW, Donnelly F, Ross M, Habib FK. Serenoa repens (Permixon): a
5alpha-reductase types I and II inhibitor&#8212;new evidence in a coculture model of BPH. <em>
Prostate</em> 1999;40:232&#8211;41.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Herb/Saw_Palmetto.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:33:18 GMT -->
</html>

